Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Clinical application of the Innovance D-dimer assay in the diagnosis of acute pulmonary thromboembolism.

Bai Z, Huang Y, Song C, Liu H, Chen Y, Zhang H, Lu X, Song Y, Zhang X.

Exp Ther Med. 2017 Jun;13(6):3543-3548. doi: 10.3892/etm.2017.4400. Epub 2017 Apr 28.

2.

Comparison of PESI, echocardiogram, CTPA, and NT-proBNP as risk stratification tools in patients with acute pulmonary embolism.

Vamsidhar A, Rajasekhar D, Vanajakshamma V, Lakshmi AY, Latheef K, Siva Sankara C, Obul Reddy G.

Indian Heart J. 2017 Jan - Feb;69(1):68-74. doi: 10.1016/j.ihj.2016.07.010. Epub 2016 Aug 1.

3.

Assessment of Prognostic Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Patients with Pulmonary Embolism.

Karataş MB, İpek G, Onuk T, Güngör B, Durmuş G, Çanga Y, Çakıllı Y, Bolca O.

Acta Cardiol Sin. 2016 May;32(3):313-20.

4.

Evaluation of cardiac biomarkers and right ventricular dysfunction in patients with acute pulmonary embolism.

Dursunoğlu N, Dursunoğlu D, Yıldız Aİ, Rota S.

Anatol J Cardiol. 2016 Apr;16(4):276-82. doi: 10.5152/akd.2014.5828. Epub 2014 Dec 31.

5.

Serum Iron Level Is Associated with Time to Antibiotics in Cystic Fibrosis.

Gifford AH, Dorman DB, Moulton LA, Helm JE, Griffin MM, MacKenzie TA.

Clin Transl Sci. 2015 Dec;8(6):754-8. doi: 10.1111/cts.12358. Epub 2015 Dec 8.

6.

Impact of cancer on the effectiveness of cardiac Troponin I to predict right ventricular dysfunction in acute pulmonary embolism.

Keller K, Geyer M, Beule J, Coldewey M, Balzer JO, Dippold W.

Thorac Cancer. 2015 Sep;6(5):584-8. doi: 10.1111/1759-7714.12226. Epub 2015 Jan 22.

7.

Leukocytes and systemic inflammatory response syndrome as prognostic factors in pulmonary embolism patients.

Jo JY, Lee MY, Lee JW, Rho BH, Choi WI.

BMC Pulm Med. 2013 Dec 10;13:74. doi: 10.1186/1471-2466-13-74.

8.

Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism.

Neto-Neves EM, Sousa-Santos O, Ferraz KC, Rizzi E, Ceron CS, Romano MM, Gali LG, Maciel BC, Schulz R, Gerlach RF, Tanus-Santos JE.

J Cell Mol Med. 2013 Dec;17(12):1588-97. doi: 10.1111/jcmm.12163. Epub 2013 Nov 6.

9.

Significance of serum cardiac troponin I levels in pulmonary embolism.

Kilinc G, Dogan OT, Berk S, Epozturk K, Ozsahin SL, Akkurt I.

J Thorac Dis. 2012 Dec;4(6):588-93. doi: 10.3978/j.issn.2072-1439.2012.10.13.

10.

Cardiac biomarkers in the intensive care unit.

McLean AS, Huang SJ.

Ann Intensive Care. 2012 Mar 7;2:8. doi: 10.1186/2110-5820-2-8.

11.

Venous thromboembolic disease.

Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogarty PF, Gao S, Garcia-Aguilar J, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Jones KA, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Smith JL, Yee GC, Zakarija A.

J Natl Compr Canc Netw. 2011 Jul 1;9(7):714-77. No abstract available.

12.

Outcome of thrombolysis for massive pulmonary embolism.

Aniteye E, Tettey M, Sereboe L, Edwin F, Kotei D, Doku A, Tamatey M, Enstuah-Mensah K, Delia I, Frimpong-Boateng K.

Ghana Med J. 2009 Mar;43(1):19-23.

13.

Prognostic stratification of acute pulmonary embolism: focus on clinical aspects, imaging, and biomarkers.

Masotti L, Righini M, Vuilleumier N, Antonelli F, Landini G, Cappelli R, Ray P.

Vasc Health Risk Manag. 2009;5(4):567-75. Epub 2009 Jul 14. Review.

14.

Diagnosis of pulmonary embolism in the coronary care unit.

Stein PD, Sostman HD, Hull RD, Goodman LR, Leeper KV Jr, Gottschalk A, Tapson VF, Woodard PK.

Am J Cardiol. 2009 Mar 15;103(6):881-6. doi: 10.1016/j.amjcard.2008.11.040. Epub 2009 Jan 24. Review.

15.

Troponin: the biomarker of choice for the detection of cardiac injury.

Babuin L, Jaffe AS.

CMAJ. 2005 Nov 8;173(10):1191-202. Review. Erratum in: CMAJ. 2005 Dec 6;173(12):1490. CMAJ. 2006 Jan 31;174(3):353.

Supplemental Content

Support Center